Rocío Parrilla

Interventional cardiology. HUJ. Primum non nocere 👩‍⚕️💔💉

[CorazonHuvr @CorazonHuvr]

III Curso sobre Abordaje Integral de la Enfermedad Coronaria Compleja: Fisiología, Imagen y Aterectomía. Ponentes y moderadores de alto nivel, casos enlatados y casos en directo @EvaRumiz @JuradoRomanAl @AntonioGomezM21 @pepp183 @MPAOSS @RosaCP8 @cardiojsl

[ForoEpic @foroepic]

🧑‍🚀LAAO, Houston we have a problem!
Rocío Parrilla @rociomd8 - Sección de Cardiología Intervencionista Hospital Universitario de Jaen.

🎬Edited by: @RumoJose , @foroic & @pipecardio.

[Salvatore Brugaletta @sbrugaletta]

How many would like to learn how to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in #TAVI? here
a very useful problem-solving step-by-step tutorial. a patient-centered learning for free and accessible to everyone. @PCRonline @escardio @akiko704 @kiadeb87 @TCTMD @crfheart @secardiologia @shci_sec
https://t.co/P6cF9bOoGg

[Felipe Díez del Hoyo @Felipediezhoyo]

📌 Habemos nuevas Guías 📖 de Valvulopatías 🇪🇺 en #ESCCongress

📝¿Qué hay de nuevo?

✏️Hilazo 🧵 de los principales cambios desde mi pt de vista 👇👇👇

✅Y por supuesto enorme 👏 a @RosselloXavier y la gran Esther Pérez-David (mi adjunta 😊) por la contribución 🇪🇸

[Felipe Díez del Hoyo @Felipediezhoyo]

🎯INSUFICIENCIA MITRAL SECUNDARIA

📝Fundamental ir integrando la clasificación ATRIAL vs VENTRICULAR

[Erik Rafflenbeul @KardiologieHH]

🚨 Breaking News from #ESCCongress:
The 2025 ESC/EACTS Guidelines on Valvular Heart Disease are out!

Key updates:
🫀 Heart Teams & advanced imaging central to diagnosis & treatment
🫀 #TAVI extended to ≥70y anatomically suitable tricuspid AS pts, regardless of surgical risk
🫀 New Class IIa: early intervention in asymptomatic severe high-gradient AS
🫀 New Class I: early surgical repair for asymptomatic severe primary MR
🫀 TEER upgraded:
 ✔ Class IIa for high-risk primary MR
 ✔ Class I for HF + severe secondary MR with LVEF <50%
🫀 Stronger role for tricuspid surgery & emerging TTVI for high-risk pts
🫀 Updated antithrombotic & valve dysfunction recommendations
🫀 New sections: cancer + VHD, acute HF, multiple/mixed VHD, and sex-specific management

📖 Full text in @ESC_Journals:
👉 🔗https://t.co/l64WB6HZBh

#VHD #CardioX #ESC2025 #EACTS

[Emilio Constán @ConstanEmilio]

Implantation of the first Aveir dual-chamber leadless pacemaker in Andalucia. Thanks to @ManoloMolina8 for his invaluable assistance. @HospitalJaen @JTLLERGO @AbbottCardio

[Mónica Fernández Quero @Monicaferqu]

Creación del grupo de trabajo de Hemodinámica de la Sociedad Andaluza de Cardiología @SACardiologia . @DrVictorBecerra @pepp183 @MPAOSS @JTLLERGO @AntonioGomezM21 @MAROSFO @alejandripc2 @OjedaOjeda18

[Emil Nielsen Holck @EmilHolckMD]

🔥 First-in-human report: Treatment t of a coronary bifurcation core perforation with dual covered stents!

Take-home
🥽 Prepare in the wet lab
🫀 Complex PCI techniques can be needed in ACS patients
🚨 Stepwise bifurcation treatment was key!

https://t.co/GXmlWxJBzC

[PCRonline 🫀 @PCRonline]

ROLLER COASTR-EPIC22: Rotational atherectomy, lithotripsy, or laser for calcified coronary stenosis

🔗https://t.co/bXY4yH4R3I

Read this #EAPCI/PCR Journal Club review ✍️of the first randomised trial comparing RA, IVL, and ELCA for calcified coronary lesions, by @aayshacader and @ANazmiCalik.

#calcifiedlesions #CHIP #interventionalcardiology #JournalClub

[The Heart @ZHeart11768530]

🔴Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions ⤵️State-Of-The-Art #2024Review @JACCJournals

🔹https://t.co/5flALcUEiU
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded

[Belén Cid Alvarez @belcid7]

En el #DíaMundialdelCorazón recordamos que los programas Código Infarto salvan vidas @shci_sec

✅17 redes Código IAM, 83 centros
➡️87,5% ICPp
⏱PCM a reperfusión 107 min
👥Trabajo en equipo @enferhemo @AgudosSEC @secardiologia

#SanidadPública

https://t.co/7V0in1zRJh…

[Diego Segura-Rodríguez @SeguraCardio]

📌#Antithrombotic ­ther­a­py in 👥 with AF &amp; acute or chron­ic coro­nary syn­dromes

Key algorithm📝

#Afib #CCS #DOAC

[Felipe Díez del Hoyo @Felipediezhoyo]

📌Por último, cobra mucha importancia el INOCA (la angina con coronarias "normales")
📝 Cuidado, el orden importa. Primero detectamos isquemia, después tratamos, si persisten síntomas estudiamos la micro
📝Se mojan en protocolo (@egutiMD crack)
📝 Se mojan en tratamiento 🆕

[Felipe Díez del Hoyo @Felipediezhoyo]

🙋‍♂️ ¿Cirugía (CABG 🔪) o ICP (🎈 🗑 )?
Pues depende de 3 factores
📝 Complejidad anatómica. A mayor complejidad, +🔪
📝 Diabetes: +🔪
📝 Riesgo QX. Aspecto a mi juicio fundamental dado que mayormente tratamos pacientes
Esta figura de guías de GPC revascularización, la biblia 👇

[Felipe Díez del Hoyo @Felipediezhoyo]

📌¿Y por qué es importante la probabilidad pre-test?
🙋‍♂️Pues porque determina qué prueba diagnóstica y pronóstica tienes que hacer
Paso 3: CONFIRMACIÓN
✅ &lt;5%: Nada más. Descartamos
✅ 5-85%: Give me something more
✅ &gt;85%: Cateterismo
Buenísima y clarificadora figura 👇👇👇

[FRANCESCO BURZOTTA @BURZOTTA_F]

After years… we have finally been able to summarize all the tricks we endorsed or developed… Indeed, we STRONGLY BELIEVE that the benefit of transcatheter procedures like #PCI #Impella #ECMO #TAVR often depends on how we deal with the arterial access!!! Thank you to the TEAM!

[Davide Capodanno @DFCapodanno]

This state-of-the-art review provides a description of the device-related thrombotic risk associated with transcatheter structural heart interventions and of the current evidence-based guidelines regarding antithrombotic treatments. Gaps in evidence for each of the studied transcatheter interventions and the main ongoing trials are also summarised. https://t.co/b4Kx4DAyDP

[Rocío Parrilla @rociomd8]

@Monicaferqu @JesusPeM17 @CorazonHuvr Un auténtico crack!!! 👏🏻👏🏻👏🏻

[Rocío Parrilla @rociomd8]

Another year enjoying and learning at the best congress in the world❤️. Thank you very much, team! Waiting for the next one!!! 💫
#euroPCR2024